COMMUNIQUÉS West-GlobeNewswire

-
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2025
06/05/2025 -
Amwell makes grant to new employee under inducement plan
06/05/2025 -
BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress
06/05/2025 -
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
06/05/2025 -
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
06/05/2025 -
WW International, Inc. Announces First Quarter 2025 Results
06/05/2025 -
Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
06/05/2025 -
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06/05/2025 -
Voyager Reports First Quarter 2025 Financial and Operating Results
06/05/2025 -
Standard BioTools Reports First Quarter 2025 Financial Results
06/05/2025 -
Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
06/05/2025 -
CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3
06/05/2025 -
Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease
06/05/2025 -
Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering
06/05/2025 -
Annual NMDP(SM) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell Therapy
06/05/2025 -
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
06/05/2025 -
Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction
06/05/2025 -
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/05/2025 -
EssilorLuxottica: Disclosure of transactions in own shares
06/05/2025
Pages